Skip to main content
Signal8

Wherley Joel L

SEC insider (Form 3/4/5 filer). CIK 0002083070. CEO - Vitas Healthcare at CHEMED CORP (CHE). 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in CINCINNATI, OH.

Companies Wherley Joel L has filed insider reports for

  • CHEMED CORP (CHE): Officer, CEO - Vitas Healthcare
Wherley Joel L profile photo

Wherley Joel L

CIK: 0002083070

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (37.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CHEMED CORP logo
CHE

CHEMED CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Oct 20, 2026
    Award

    Stock Option (right to buy with tandem tax withholding)

    Direct
    12.7K shares at avg. $512.64-
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Aug 5, 2026
    Tax Payment
    Direct
    2.3K shares at avg. $542.62$1.2M
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Aug 5, 2026
    Exercise
    Direct
    2.6K shares at avg. $445.35$1.2M
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Feb 13, 2026
    Tax Payment
    Direct
    80 shares at avg. $469.56$38K
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Feb 13, 2026
    Award

    Performance Stock Units

    Direct
    1.1K shares-
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Feb 13, 2026
    Exercise
    Direct
    273 shares at avg. $469.56$128K
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Feb 13, 2026
    Exercise
    Direct
    0 shares at avg. $469.56-
  • CHEMED CORP logo
    CHE

    CHEMED CORP

    Oct 21, 2025
    Award

    Stock Option (right to buy with tandem tax withholding)

    Direct
    17.5K shares at avg. $443.79-

1-8 of 8